Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information
Equipping Healthcare Professionals with the Necessary Tools for Improving Care in Ovarian Cancer
Choose from the criteria below to find an activity that fits you best.
Attend both webinars to get the most from this series!
Overview, Guidelines, and Pharmacotherapy Options
Advances in Injectable Therapies and Overcoming Barriers to Care
The primary purpose of this program is to improve the knowledge and competence of pharmacists regarding obesity management, with an emphasis on the safe use, dosing, titration, and administration of injectable obesity treatment options. The program will consist of 4 microlearning modules, presented live in 2 separate 45 minutes sessions on 2 separate dates.
The target audience for this program is pharmacists, including clinical, community, specialty, and managed care pharmacists who care for patients with obesity, as well as pharmacy directors, chief pharmacy officers, and other stakeholders in pharmacy practice. At the completion of this activity, the participant will be able to:
Megan Adelman, PharmD, BCPS, BCGP, CDCES
Family Medicine Pharmacy Specialist
Center for Family Medicine
Cleveland Clinic Akron General
Elizabeth Pogge, PharmD, MPH, BCGP, BCPS-AQ Cardiology, FASCP, FAzPA
Professor, Midwestern University College of Pharmacy
ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Numbers 0221-0000-22-036-L01-P and 0221-0000-22-037-L01-P have been assigned to these live knowledge-based activities (initial release dates February 23 and March 1, 2022 respectively). Each activity is approved for 0.75 contact hour (0.075 CEU) in states that recognize ACPE providers. The activities are provided at no cost to participants. Participants must complete the online post-test and activity evaluation within 30 days of each activity to receive pharmacy CE credit. No partial credit will be given. Statements of completion will be issued online at www.ProCE.com, and proof of completion will be posted in NABP CPE Monitor profiles.
ProCE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learners with high-quality CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. Faculty disclosures will be provided prior to the start of the CE activities.
These activities are supported by an educational grant from Novo Nordisk Inc.
Webinar Equipment Requirements
-Computer with broadband Internet access
-Soundcard and speakers or headphones for your computer (or dial-in via telephone for audio)
Click here for detailed software requirements.
The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.